Novanta NOVT Medical Solutions — Selling General And Administrative Expense

Other segment segments

Similar metrics at other companies

MDTMedical Surgical — Selling, general, and administrative expense

$650M+9.6%

BDXMedical — Selling and administrative expense

$328M+27.3%

BDXMedical Essentials — Selling and administrative expense

$185M+12.8%

REZIProducts and Solutions — Selling, general and administrative expenses

$119M+17.8%

NDSNMedical and Fluid Solutions — Adjusted selling and administrative expenses

-$33.32M+0.8%

WMHealthcare Solutions — Selling General And Administrative Expense

$122M-21.8%

Questions, answered.

What is Novanta's medical solutions — selling general and administrative expense?

Novanta (NOVT) reported medical solutions — selling general and administrative expense of $16.31M in Q1 2026.

How has Novanta's medical solutions — selling general and administrative expense changed year-over-year?

Novanta's medical solutions — selling general and administrative expense increased by 10.7% year-over-year, from $14.73M to $16.31M.

What is the long-term trend for Novanta's medical solutions — selling general and administrative expense?

Over 3 years (2022 to 2025), Novanta's medical solutions — selling general and administrative expense has grown at a 12.1% compound annual growth rate (CAGR), from $42.63M to $60.03M.

What does medical solutions — selling general and administrative expense mean?

Operating expenses for the Medical Solutions segment that are not directly tied to production, including sales commissions, marketing, administrative salaries, and overhead. This metric tracks the efficiency of the segment's support functions and commercial infrastructure.